Diploma PLC (LON:DPLM) Stock Has Average Target Price of GBX 7,400

Diploma PLC (LON:DPLM) has received a consensus rating of “Moderate Buy” from the eight research firms that are covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is GBX 7,400.

A number of brokerages have recently commented on DPLM. JPMorgan Chase & Co. boosted their price objective on shares of Diploma from GBX 5,760 to GBX 8,250 and gave the stock an “overweight” rating in a research report on Monday, August 24th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a GBX 7,400 target price on shares of Diploma in a research report on Tuesday, September 8th. Finally, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 9,000 target price on shares of Diploma in a research report on Monday, July 20th.

Insider Buying and Selling at Diploma

In related news, insider Katie Bickerstaffe  bought 246 shares of the company’s stock in a transaction that occurred on Wednesday, September 23rd. The shares were acquired at an average price of GBX 7,696 per share, for a total transaction of £18,932.16. 1.14% of the stock is owned by insiders.

Diploma Price Performance

Shares of DPLM stock opened at GBX 7,800.76 on Tuesday. Diploma has a 12-month low of GBX 4,970 and a 12-month high of GBX 7,980. The firm has a market capitalization of £10.46 billion, a price-to-earnings ratio of 55.40, a price-to-earnings-growth ratio of 2.82 and a beta of 0.92. The company has a quick ratio of 0.80, a current ratio of 2.06 and a debt-to-equity ratio of 47.65. The firm has a fifty day moving average of GBX 7,442.58 and a 200-day moving average of GBX 7,127.28.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.